MSCopilot Flower mobile application
DeviceMSCopilot Flower includes active tests for walking, cognition, dexterity and vision, and e-questionnaires related to fatigue and Anxiety
NCT Number: NCT06922942
This US multicenter, prospective cohort study aims to evaluate how MSCopilot can be seamlessly integrated into the current care pathway and identify potential optimizations to enhance its impact on both MS patients and clinicians, facilitating broader implementation. Specifically, the study will assess:
* The overall integration of MSCopilot into routine clinical practice, * Patients' ability to use MSCopilot at home without supervision, * The need for patient support when using MSCopilot at home, * User behavior based on usage analytics data from the MSCopilot mobile app and dashboard, * Patient adherence to MSCopilot use in routine clinical practice, * The adequacy of the onboarding/training process for HCPs, * The effectiveness of HCPs onboarding/training in ensuring successful patient onboarding, * The variances in user behavior and adherence to MSCopilot use according to socio-demographic factors and EDSS scores
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Jenny Feng, New Orleans, Louisiana, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For patients
For HCPs:
Exclusion criteria
(for patients):
Early termination criteria (for patients):
MSCopilot Flower includes active tests for walking, cognition, dexterity and vision, and e-questionnaires related to fatigue and Anxiety
Time frame: For neurologists: Day 180 (+/- 30 days) and for patients: Day 1, Day 90 and Day 180 (+/- 30 days)
Descriptive analysis and acceptance criteria of a minimum score of >2/4 on neurologists' questionnaires regarding the ease of integrating the MSCopilot dashboard into clinical workflows Descriptive analysis and acceptance criteria of a minimum score of >2/4 on patients' questionnaires regarding the ease of use of MSCopilot at home
Time frame: At Day 180 ± 30days
Descriptive analysis of neurologists' questionnaires, to be completed after each investigator's last visit, regarding the Health Care Profesionnals (HCPs) dashboard Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item, of neurologists' questionnaires after the last visit on the HCPs dashboard Descriptive analysis of patients' questionnaires after the last visit regarding MSCopilot app and dashboard use by the HCPs.
Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item in patients' questionnaires, to be completed after the follow-up visit, regarding MSCopilot application and dashboard use by HCPs
Time frame: Day 1 (+/- 30 days)
Descriptive analysis of patient questionnaires Acceptance criteria of a minimum of >2/4 for each item, of patient questionnaires
Time frame: Day 90 (+/-30 days)
Descriptive analysis of patient questionnaires at mid-study Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item, of patient questionnaires at mid-study
Time frame: Day 180 (+/-30 days)
Descriptive analysis of nurses or medical assistants' questionnaires (if applicable) Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item, of nurses or medical assistants' questionnaires (if applicable)
Time frame: Day 1 to Day 180 (+/-30 days)
Descriptive analysis of the mobile application's adherence data, including:
Number of performed tests, Number of performed sessions, Number of completed questionnaires.
Time frame: Day 1 to Day 180 (+/-30 days)
Quantitative analysis of real-world utilization patterns of the MSCopilot mobile app through analytics data Quantitative analysis of real-world utilization patterns of the HCPs dashboard through analytics data
Time frame: At the end of inclusion period (90 days)
Descriptive analysis of HCPs (neurologists) questionnaires Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item, of HCPs (neurologists) questionnaires
Time frame: After patient inclusion visit (90 days)
Descriptive analysis of patient questionnaires Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item, of patient questionnaires
Time frame: After onboarding/training session (Day 0)
Descriptive analysis of HCPs questionnaires post-onboarding/training session Descriptive analysis and acceptance criteria of a minimum score of >2/4 for each item in HCPs questionnaires post-onboarding/training
Time frame: Day 1 to Day 180 (+/-30 days)
Descriptive analysis of how socio-demographic factors and EDSS scores affect patient behavior and adherence to MSCopilot mobile application.
Time frame: Day 1 to Day 180 (+/-30 days)
Descriptive analysis of how HCPs socio-demographic factors affect their behavior toward MSCopilot dashboard.
Ad scientiam
Other
MS-FLOWER: MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
Acronym: MS-FLOWER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04544436
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Cullman, Alabama, United States
View Trial DetailsNCT04548999
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Homewood, Alabama, United States
View Trial DetailsNCT06141473
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Birmingham, Alabama, United States
View Trial DetailsNCT07705581
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Graz, Austria
View Trial Details